BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 21206486)

  • 1. Physical activity recommendations, exercise intensity, and histological severity of nonalcoholic fatty liver disease.
    Kistler KD; Brunt EM; Clark JM; Diehl AM; Sallis JF; Schwimmer JB;
    Am J Gastroenterol; 2011 Mar; 106(3):460-8; quiz 469. PubMed ID: 21206486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethnicity and nonalcoholic fatty liver disease.
    Bambha K; Belt P; Abraham M; Wilson LA; Pabst M; Ferrell L; Unalp-Arida A; Bass N;
    Hepatology; 2012 Mar; 55(3):769-80. PubMed ID: 21987488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Editorial: Exercise for NAFLD: does intensity matter?
    Conjeevaram HS; Tiniakos DG
    Am J Gastroenterol; 2011 Mar; 106(3):470-5. PubMed ID: 21378763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between metabolic syndrome and liver histology among children with nonalcoholic Fatty liver disease.
    Patton HM; Yates K; Unalp-Arida A; Behling CA; Huang TT; Rosenthal P; Sanyal AJ; Schwimmer JB; Lavine JE
    Am J Gastroenterol; 2010 Sep; 105(9):2093-102. PubMed ID: 20372110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease.
    Neuschwander-Tetri BA; Clark JM; Bass NM; Van Natta ML; Unalp-Arida A; Tonascia J; Zein CO; Brunt EM; Kleiner DE; McCullough AJ; Sanyal AJ; Diehl AM; Lavine JE; Chalasani N; Kowdley KV;
    Hepatology; 2010 Sep; 52(3):913-24. PubMed ID: 20648476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease.
    Kowdley KV; Belt P; Wilson LA; Yeh MM; Neuschwander-Tetri BA; Chalasani N; Sanyal AJ; Nelson JE;
    Hepatology; 2012 Jan; 55(1):77-85. PubMed ID: 21953442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histopathological stages of nonalcoholic fatty liver disease in type 2 diabetes: prevalences and correlated factors.
    Leite NC; Villela-Nogueira CA; Pannain VL; Bottino AC; Rezende GF; Cardoso CR; Salles GF
    Liver Int; 2011 May; 31(5):700-6. PubMed ID: 21457442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ADH1B∗2 Is Associated With Reduced Severity of Nonalcoholic Fatty Liver Disease in Adults, Independent of Alcohol Consumption.
    Vilar-Gomez E; Sookoian S; Pirola CJ; Liang T; Gawrieh S; Cummings O; Liu W; Chalasani NP
    Gastroenterology; 2020 Sep; 159(3):929-943. PubMed ID: 32454036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-alcoholic fatty liver disease - histological scoring systems: a large cohort single-center, evaluation study.
    Rastogi A; Shasthry SM; Agarwal A; Bihari C; Jain P; Jindal A; Sarin S
    APMIS; 2017 Nov; 125(11):962-973. PubMed ID: 29076589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and histological determinants of nonalcoholic steatohepatitis and advanced fibrosis in elderly patients.
    Noureddin M; Yates KP; Vaughn IA; Neuschwander-Tetri BA; Sanyal AJ; McCullough A; Merriman R; Hameed B; Doo E; Kleiner DE; Behling C; Loomba R;
    Hepatology; 2013 Nov; 58(5):1644-54. PubMed ID: 23686698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying Nonalcoholic Fatty Liver Disease Advanced Fibrosis in the Veterans Health Administration.
    Patel YA; Gifford EJ; Glass LM; Turner MJ; Han B; Moylan CA; Choi S; Suzuki A; Provenzale D; Hunt CM
    Dig Dis Sci; 2018 Sep; 63(9):2259-2266. PubMed ID: 29779083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for biopsy-proven advanced non-alcoholic fatty liver disease in the Veterans Health Administration.
    Patel YA; Gifford EJ; Glass LM; McNeil R; Turner MJ; Han B; Provenzale D; Choi SS; Moylan CA; Hunt CM
    Aliment Pharmacol Ther; 2018 Jan; 47(2):268-278. PubMed ID: 29115682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical utility of biomarkers and the nonalcoholic steatohepatitis CRN liver biopsy scoring system in patients with nonalcoholic fatty liver disease.
    Malik R; Chang M; Bhaskar K; Nasser I; Curry M; Schuppan D; Byrnes V; Afdhal N
    J Gastroenterol Hepatol; 2009 Apr; 24(4):564-8. PubMed ID: 19378390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the BARD scoring system in Polish patients with nonalcoholic fatty liver disease (NAFLD).
    Raszeja-Wyszomirska J; Szymanik B; Ławniczak M; Kajor M; Chwist A; Milkiewicz P; Hartleb M
    BMC Gastroenterol; 2010 Jun; 10():67. PubMed ID: 20584330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life in adults with nonalcoholic fatty liver disease: baseline data from the nonalcoholic steatohepatitis clinical research network.
    David K; Kowdley KV; Unalp A; Kanwal F; Brunt EM; Schwimmer JB;
    Hepatology; 2009 Jun; 49(6):1904-12. PubMed ID: 19434741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel plasma biomarkers associated with liver disease severity in adults with nonalcoholic fatty liver disease.
    Ajmera V; Perito ER; Bass NM; Terrault NA; Yates KP; Gill R; Loomba R; Diehl AM; Aouizerat BE;
    Hepatology; 2017 Jan; 65(1):65-77. PubMed ID: 27532276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of Nonalcoholic Steatohepatitis-Associated Cirrhosis in the United States: An Analysis of National Health and Nutrition Examination Survey Data.
    Kabbany MN; Conjeevaram Selvakumar PK; Watt K; Lopez R; Akras Z; Zein N; Carey W; Alkhouri N
    Am J Gastroenterol; 2017 Apr; 112(4):581-587. PubMed ID: 28195177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biopsy rate and nonalcoholic steatohepatitis (NASH) in patients with nonalcoholic fatty liver disease (NAFLD).
    Gerhardt F; Petroff D; Blank V; Böhlig A; van Bömmel F; Wittekind C; Berg T; Karlas T; Wiegand J
    Scand J Gastroenterol; 2020 Jun; 55(6):706-711. PubMed ID: 32476514
    [No Abstract]   [Full Text] [Related]  

  • 19. Is increased red cell distribution width an indicating marker of nonalcoholic steatohepatitis and fibrotic stage?
    Cengiz M; Candır BA; Yılmaz G; Akyol G; Ozenirler S
    World J Gastroenterol; 2013 Nov; 19(42):7412-8. PubMed ID: 24259972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathologic criteria for nonalcoholic steatohepatitis: interprotocol agreement and ability to predict liver-related mortality.
    Younossi ZM; Stepanova M; Rafiq N; Makhlouf H; Younoszai Z; Agrawal R; Goodman Z
    Hepatology; 2011 Jun; 53(6):1874-82. PubMed ID: 21360720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.